Worldwide Pharmaceutical Sales Force Levels Decline by Only 1.8% in 2011

Cegedim Strategic Data (CSD), a market leader in providing healthcare market research and worldwide promotional audits, has unveiled the results of its audit concerning global pharmaceutical sales force levels in 2011.

Despite the weakness of many western economies at this time, economic difficulty within the industry has been tempered by the growth of many non-traditional economic powerhouses, in particular emerging markets such as China, which has led to a relatively favourable decline compared to other industries of just 1.8%.

The United States remains the leading country for number of sales reps, with 73, 762, closely followed by China with 65, 827 and Japan with 54, 236.  Despite being the largest in the world for number of reps in total, the United States saw a 7 percent decrease in its total number of sales reps compared to 2010, and Japan saw a drop of 10 percent.  In comparison, China continued to demonstrate extremely strong growth, with an increase of 18.6 percent.

In Europe, the top five markets were a mixed bag, with Spain and the United Kingdom remaining relatively stable, Italy and Germany showing small declines of 1.7 percent and 2 percent respectively, and France showing a very large decline of 12 percent.

All of this means that, considering the current state of the global economy, any form of stability means a healthy industry, and pharma industry jobs are certainly doing well.  This is also true for orthopaedic sales jobs, with the two industries so closely related, and those with experience in these fields can look forward to some very good prospects.

In addition to China, the other BRIC countries are also demonstrating good growth, and Brazilian sales forces have increased by 3.5 percent, which places the country fifth in the world for the number of sales reps.

Share |